Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc., a leading biopharmaceutical company headquartered in the United States, focuses on developing innovative treatments for skin diseases. Founded in 2018, Verrica has quickly established itself in the dermatology sector, particularly in the treatment of conditions such as molluscum contagiosum. The company’s flagship product, VP-102, is a unique topical therapy that utilises a proprietary formulation to effectively target viral skin infections. This innovative approach sets Verrica apart in a competitive market, positioning it as a key player in dermatological therapeutics. With a commitment to advancing patient care, Verrica Pharmaceuticals continues to make significant strides in the industry, aiming to improve the quality of life for those affected by challenging skin conditions.
DitchCarbon Score
How does Verrica Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Verrica Pharmaceuticals Inc.'s score of 13 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Verrica Pharmaceuticals Inc.'s reported carbon emissions
Verrica Pharmaceuticals Inc., headquartered in the US, currently does not have publicly available carbon emissions data for recent years, nor does it outline specific reduction targets or initiatives. Without concrete emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, as a player in the pharmaceutical industry, Verrica is likely aware of the growing importance of climate commitments and may be exploring strategies to align with industry standards. The absence of data suggests a potential area for improvement in transparency and accountability regarding their environmental footprint.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Verrica Pharmaceuticals Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
